News results: "OSI Pharmaceuticals"

« 6 results in "Health"« 1 results in "Specials"« 1 results in "Business"
dotclear

Health

Study: Tarceva Delays Progress Of Lung Cancer

Study: Tarceva Delays Progress Of Lung Cancer

Tarceva’s manufacturers, Genetech Inc and OSI Pharmaceuticals, said the drug proved its...
» read full story November 09th, 2008 - 13:31
Lung Cancer Treatment Drug Tarceva Makes the Disease Possible To Treat

Lung Cancer Treatment Drug Tarceva Makes the Disease Possible To Treat

The drug Tarceva, made by OSI Pharmaceuticals has been found to cause an increase in survival rates...
» read full story November 08th, 2008 - 23:55
Tarceva Slows Progress Of Lung Cancer, Study Shows

Tarceva Slows Progress Of Lung Cancer, Study Shows

After a study disclosed that the drug Tarceva was efficient in prolonging lung cancer survival when...
» read full story November 08th, 2008 - 14:33
OSI Shares Gain, Despite Preliminary Results, Tarceva Meets Its Goal

OSI Shares Gain, Despite Preliminary Results, Tarceva Meets Its Goal

Shares of OSI Pharmaceutical rose $5.25, or 15 percent, to $40.65 at 4 p.m. New York time in Nasdaq...
» read full story November 08th, 2008 - 14:30
Tarceva-Avastin Combination Doesn’t Prolong Lung Cancer Survival

Tarceva-Avastin Combination Doesn’t Prolong Lung Cancer Survival

According to the results of a late-stage clinical trial into the benefits of combining Genentech’s...
» read full story October 07th, 2008 - 14:00
Two-Drug Combination Isn’t Up To Snuff In Lung-Cancer Trial

Two-Drug Combination Isn’t Up To Snuff In Lung-Cancer Trial

Genentech Inc. and OSI Pharmaceuticals Inc., two leading biotechnology companies, announced Monday...
» read full story October 06th, 2008 - 22:31
dotclear

Specials

Study: Lung Cancer Drug Tarceva Slows Progression of the Disease

Study: Lung Cancer Drug Tarceva Slows Progression of the Disease

Lung cancer drug Tarceva jointly developed by OSI Pharmaceuticals Inc., Genentech Inc. and Roche...
» read full story November 10th, 2008 - 15:08
dotclear

Business

OSI Shares Gain After Study Shows Tarceva Meets Its Goal

OSI Shares Gain After Study Shows Tarceva Meets Its Goal

Shares of OSI Pharmaceutical rose $5.25, or 15 percent, to $40.65 at 4 p.m. New York time in Nasdaq...
» read full story November 10th, 2008 - 06:58
dotclear
dotclear
dotclear
Photos Gallery
dotclear